These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2012-005410-19 Developing a Patient Model of Controlled, Radial Artery Access Site Bleeding for Deciding on Anticoagulation Reversal in Patients Treated by Systemic Anticoagulants. not-yet-due
Completed, but no date 2015-003987-35 Metamizole versus NSAID at home after ambulatory surgery: a double-blind randomized controlled trial Metamizole versus NSAID voor pijnstilling thuis na ambulante chirurgie: een dubbelblind gerandom... bad-data
Not reported 2019-002801-23 Evaluation of the added value of Metamizole to standard post-operative treatment after ambulant surgery: a double-blind, randomized controlled trial 2022-02-07 due-trials
Ongoing 2019-004003-12 Implementation of pre-emptive geno- and phenotyping in 5-FU- or capecitabine-treated patients with the aim of reducing toxicity Implementatie van preemptieve geno- en fenotypering bij behandeling m... not-yet-due
Ongoing 2020-001714-38 Alkaline phosphatase for reducing systemic inflammatory response syndrome (SIRS) in patients with Sars-CoV-2 infection and acute respiratory insufficiency (COVID 19) not-yet-due
Not reported 2020-004237-21 Evaluation of the added value of Metamizole to standard postoperative treatment after ambulant shoulder surgery: a double-blind, randomized controlled trial 2022-12-22 due-trials
Completed, report not yet due 2021-004562-35 Low dose versus normal dose ketorolac for postoperative pain after prostatectomy and hysterectomy: a Double-blind Randomized Controlled Non-inferiority Trial 2024-09-05 not-yet-due